Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
Nemet I, Kliker L, Lustig Y, Zuckerman N, Erster O, Cohen C, Kreiss Y, Alroy-Preis S, Regev-Yochay G, Mendelson E, Mandelboim M. Nemet I, et al. Among authors: kliker l. N Engl J Med. 2022 Feb 3;386(5):492-494. doi: 10.1056/NEJMc2119358. Epub 2021 Dec 29. N Engl J Med. 2022. PMID: 34965337 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 34023883
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Lustig Y, Zuckerman N, Nemet I, Atari N, Kliker L, Regev-Yochay G, Sapir E, Mor O, Alroy-Preis S, Mendelson E, Mandelboim M. Lustig Y, et al. Among authors: kliker l. Euro Surveill. 2021 Jul;26(26):2100557. doi: 10.2807/1560-7917.ES.2021.26.26.2100557. Euro Surveill. 2021. PMID: 34212838 Free PMC article.
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
Barlev-Gross M, Weiss S, Paran N, Yahalom-Ronen Y, Israeli O, Nemet I, Kliker L, Zuckerman N, Glinert I, Noy-Porat T, Alcalay R, Rosenfeld R, Levy H, Mazor O, Mandelboim M, Mendelson E, Beth-Din A, Israely T, Mechaly A. Barlev-Gross M, et al. Among authors: kliker l. J Infect Dis. 2021 Aug 16;224(4):616-619. doi: 10.1093/infdis/jiab278. J Infect Dis. 2021. PMID: 34398244 Free PMC article.
The Rise and Fall of a Local SARS-CoV-2 Variant with the Spike Protein Mutation L452R.
Mor O, Mandelboim M, Fleishon S, Bucris E, Bar-Ilan D, Linial M, Nemet I, Kliker L, Lustig Y, Israel National Consortium For Sars-CoV-Sequencing, Mendelson ES, Zuckerman NS. Mor O, et al. Among authors: kliker l. Vaccines (Basel). 2021 Aug 23;9(8):937. doi: 10.3390/vaccines9080937. Vaccines (Basel). 2021. PMID: 34452062 Free PMC article.
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.
Makdasi E, Zvi A, Alcalay R, Noy-Porat T, Peretz E, Mechaly A, Levy Y, Epstein E, Chitlaru T, Tennenhouse A, Aftalion M, Gur D, Paran N, Tamir H, Zimhony O, Weiss S, Mandelboim M, Mendelson E, Zuckerman N, Nemet I, Kliker L, Yitzhaki S, Shapira SC, Israely T, Fleishman SJ, Mazor O, Rosenfeld R. Makdasi E, et al. Among authors: kliker l. Cell Rep. 2021 Sep 7;36(10):109679. doi: 10.1016/j.celrep.2021.109679. Epub 2021 Aug 21. Cell Rep. 2021. PMID: 34464610 Free PMC article.
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Zuckerman N, Nemet I, Kliker L, Atari N, Lustig Y, Bucris E, Bar Ilan D, Geva M, Sorek-Abramovich R, Weiner C, Rainy N, Bar-Chaim A, Benveniste-Levkovitz P, Abu Hamed R, Regev-Yochay G, Hevkin O, Mor O, Alroy-Preis S, Mendelson E, Mandelboim M. Zuckerman N, et al. Among authors: kliker l. Euro Surveill. 2021 Nov;26(45):2100974. doi: 10.2807/1560-7917.ES.2021.26.45.2100974. Euro Surveill. 2021. PMID: 34763751 Free PMC article.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
Gilboa M, Mandelboim M, Indenbaum V, Lustig Y, Cohen C, Rahav G, Asraf K, Amit S, Jaber H, Nemet I, Kliker L, Bar-Haim E, Mendelson E, Doolman R, Rubin C, Regev-Yochay G, Kreiss Y. Gilboa M, et al. Among authors: kliker l. J Infect Dis. 2022 Mar 2;225(5):785-792. doi: 10.1093/infdis/jiab584. J Infect Dis. 2022. PMID: 34850049
Viral co-pathogens in COVID-19 acute respiratory syndrome - what did we learn from the first year of pandemic?
Kriger O, Gefen-Halevi S, Leshem E, Smollan G, Belausov N, Egbarye A, Khashab R, Odeh M, Saffia A, Barak Y, Hussein OA, Hamias R, Aharon Y, Alfandari J, Nemet I, Kliker L, Sherbany H, Mandelboim M, Amit S. Kriger O, et al. Among authors: kliker l. Int J Infect Dis. 2022 Mar;116:226-229. doi: 10.1016/j.ijid.2022.01.018. Epub 2022 Jan 14. Int J Infect Dis. 2022. PMID: 35038602 Free PMC article.
35 results